{"id":"F2012L00990","name":"Therapeutic Goods (Listing) Notice 2012 (No. 1)","slug":"therapeutic-goods-listing-notice-2012-no-1","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":89337,"registerId":"commonwealth-F2012L00990-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2012 (No. 1)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2012 (No. 1)\n\nI, BRIAN RICHARDS, National Manager (Acting) of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n-   preparations, for the purpose of Item 3, Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘sodium molybdate dihydrate’ as a therapeutically active ingredient, subject to the following conditions:\n\n-   the preparations are for oral use only; and\n-   the preparations provide not more than 125 μg of molybdenum per daily dose.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 1st day of May 2012\n\n(signed by)\n\nBrian Richards\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1906},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This is the original 2012 instrument establishing a temporary listing for sodium molybdate dihydrate preparations. The scope remains narrow and specific to this single ingredient as originally intended."},"complexity_factors":["Single specific active ingredient specified (sodium molybdate dihydrate)","Only two straightforward conditions (oral route and dosage cap)","Minimal cross-referencing (only cites the enabling Act and Regulations provision)","Temporary mechanism with automatic cessation trigger","No interpretation section or defined terms"],"plain_english_summary":"This notice temporarily allows specific molybdenum supplements to be sold in Australia as **listed therapeutic goods** (a regulatory category for lower-risk medicines like vitamins and minerals).\n\n**What it covers:**\nPreparations containing **sodium molybdate dihydrate** (a form of the essential mineral molybdenum).\n\n**Key restrictions:**\n*   **Oral use only** — the product must be swallowed (not injected or applied to skin)\n*   **Dosage limit** — no more than 125 micrograms of molybdenum per daily dose\n\n**Why it matters:**\nTherapeutic goods normally require entry in the Australian Register of Therapeutic Goods (ARTG) before they can be legally supplied. This notice acts as a temporary entry for these specific molybdenum products while permanent regulations are being updated. Once those permanent regulations take effect, this notice automatically ceases to apply."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2012-no-1","history":"/api/acts/therapeutic-goods-listing-notice-2012-no-1/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2012-no-1/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2012-no-1/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2012-no-1/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2012-no-1/documents"}}